Combination of Narrow-Margin Hepatectomy and External Beam Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Overview

This systematic review and meta-analysis evaluates the effectiveness and safety of combining external beam radiotherapy (EBRT) with narrow-margin hepatectomy in patients with hepatocellular carcinoma (HCC). The findings suggest that this combination may reduce postoperative recurrence rates and improve overall survival compared to surgery alone.

Background

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with a high postoperative recurrence rate after hepatectomy. Achieving a safe surgical margin during hepatectomy is often challenging, particularly in cases of central tumors. As a result, there is a need for effective adjuvant treatments to improve patient outcomes following narrow-margin hepatectomy.

Data Highlights

No numerical data available in the provided source material.

Key Findings

• The combination of narrow-margin hepatectomy and EBRT may reduce postoperative recurrence rates.
• Patients receiving this combination therapy showed improved overall survival compared to those undergoing surgery alone.
• EBRT has demonstrated efficacy in controlling local recurrence in various cancers, including HCC.
• There is ongoing debate regarding the use of EBRT after narrow-margin hepatectomy, highlighting the need for further research.
• Adjuvant treatments like EBRT are increasingly considered in multidisciplinary approaches for managing HCC.

Clinical Implications

Clinicians should consider the potential benefits of combining EBRT with narrow-margin hepatectomy for HCC patients, particularly those at high risk for recurrence. This approach may enhance patient outcomes and should be discussed within a multidisciplinary treatment framework.

Conclusion

The findings from this systematic review and meta-analysis support the use of EBRT as a promising adjuvant treatment following narrow-margin hepatectomy for HCC, warranting further investigation in clinical practice.

References

1. Narrow-margin hepatectomy combined with external beam radiotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis, BMC Cancer, 2025
2. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma, EASL, 2025
3. The ASCO Post — Studies Report Efficacy of Proton Radiotherapy for Hepatocellular Carcinoma
4. European Radiology — MRI-based assessment for determining the necessity of extensive resection margins in patients with solitary hepatocellular carcinoma
5. Surgical Endoscopy — Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a multicenter propensity score-matched analysis from Eastern and Western referral centers
6. Journal of Gastrointestinal Surgery — Management and Outcomes of Fibrolamellar Hepatocellular Carcinoma: A Comprehensive Review of Current Literature and Meta-Analysis
7. Studies Report Efficacy of Proton Radiotherapy for Hepatocellular Carcinoma
8. MRI-based assessment for determining the necessity of extensive resection margins in patients with solitary hepatocellular carcinoma
9. Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm)
10. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
11. Narrow-margin hepatectomy combined with external beam radiotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis | BMC Cancer | Springer Nature Link
12. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial - ScienceDirect